Viewing Study NCT06810505


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2025-12-26 @ 1:57 AM
Study NCT ID: NCT06810505
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-01-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module